Purchase Order 75D30123P17663
Award Date
8/24/23
Potential Completion Date
9/28/23
Potential Value
$19K
Federal Agency
CDC Pittsburgh
Awardee
Inbios International Inc.
Ultimate Awardee
Not listed
NAICS Category
325413 - In-Vitro Diagnostic Substance Manufacturing
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Seattle, WA 98109, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Walsh Healy Act
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This firm-fixed-price purchase order was awarded by the Centers for Disease Control and Prevention (CDC) to Inbios International, Inc., a minority-owned, for-profit biotechnology company based in Seattle, Washington. The $61,575 contract is for the provision of Inbios' DETECT IgM Capture ELISA Kit and accessories, which are used for infectious disease diagnostics. The award does not have a set-aside designation. Inbios has received multiple previous federal contract and grant awards from the...
This federal contract award by the Centers for Disease Control and Prevention (CDC) is for the procurement of ELISA detection kits from Inbios International Inc., a minority-owned, for-profit biotechnology company based in Seattle, Washington. The contract, valued at $85,485.00, is a firm fixed-price purchase order with an ultimate completion date of April 30, 2020. Inbios is a critical partner to the government, particularly during the COVID-19 pandemic, having secured numerous contracts with...
The Centers for Disease Control and Prevention (CDC) awarded Illumina, Inc. a $160,535.84 firm fixed price purchase order for reagents. The CDC, part of the Department of Health and Human Services, will utilize the reagents in Pittsburgh, Pennsylvania as part of its efforts to advance public health. Illumina will deliver the products from its facilities in San Diego, California by September 30, 2023 to support the CDC's disease prevention and health promotion activities. No set aside designation...
The Department of Health and Human Services Centers for Disease Control and Prevention in Pittsburgh awarded a $51,390.81 purchase order contract to Innopsys, Inc. for biomedical equipment. The contract has a period of performance from August 10, 2023 to September 7, 2023 and is a firm fixed price award. It was awarded under a total small business set aside. Per the solicitation, Innopsys will provide its InnoScan 710 product to support CDC programs. As the nation's health protection agency, CDC...
The Department of State Bureau of East Asian and Pacific Affairs awarded a firm fixed-price purchase order to Inbios International Inc., a minority-owned, for-profit biotechnology company based in Seattle, Washington, for $143,218.00. The contract is for the supply of CDC 7553.0/ELISA detection kits, which are immunodiagnostic devices used for infectious disease testing. Inbios has a history of federal contract awards and grants related to the development and manufacture of diagnostic tests,...
The Department of Health and Human Services Centers for Disease Control and Prevention in Pittsburgh awarded a $86,359.80 firm fixed price purchase order to Stemcell Technologies Inc. of Kent, Washington for laboratory reagents. The contract runs from July 19, 2023 through February 15, 2024 to support CDC's research and public health programs. As a leading supplier of cell biology reagents and tools, Stemcell will provide the requested products to aid CDC's disease prevention and health...
The Department of Health and Human Services Centers for Disease Control and Prevention Pittsburgh awarded Illumina, Inc. a $46,172.80 firm fixed price purchase order for Illumina reagents. The place of performance will be Illumina's facility located in Chamblee, Georgia. The period of performance is from February 7, 2023 through August 15, 2023. CDC Pittsburgh is likely procuring the reagents to support its genomic sequencing and bioinformatics programs that help public health agencies detect,...
The Department of Health and Human Services Centers for Disease Control and Prevention Pittsburgh awarded Illumina, Inc. a $116,548 purchase order contract for laboratory equipment. The prime contractor, Illumina, Inc., will deliver the requested equipment to support HHS-CDC programs in San Diego, California by the end-date of August 25, 2023. The firm fixed price contract was awarded on July 11, 2023 to Illumina without a set-aside designation. No major subcontractors or additional context...
The Centers for Disease Control and Prevention (CDC) awarded a $29,735.58 firm fixed price purchase order to Illumina, Inc. to procure reagents in support of the agency's public health programs. As the prime contractor, Illumina will deliver the requested laboratory supplies to the CDC location in Pittsburgh, Pennsylvania within the two week period of performance from June 30, 2023 through July 13, 2023. No subcontractors or set aside designations were identified. The CDC works domestically...
This $806,303.37 cost-plus-fixed-fee delivery order contract was awarded by the Department of the Army Medical Command to Inbios International Inc., a minority-owned, for-profit biotechnology company based in Seattle, Washington. The contract is for other direct costs and does not have a set-aside designation. Inbios International specializes in the design, development, and manufacture of immunodiagnostic devices, and has received over $85 million in prime contract awards from agencies like...